120 Teens Hospitalized, 3 Dead Following Pfizer Vaccine Rollout for 15- to 17-Year-Olds in Vietnam

Region:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @crg_globalresearch.

***

The Vietnamese province of Thanh Hoa suspended a batch of Pfizer’s COVID vaccine after more than 120 teens were hospitalized after being vaccinated. According to news reports, three Vietnamese teens have died after getting the Pfizer vaccine.

The Vietnamese province of Thanh Hoa suspended a batch of Pfizer-BioNTech’s COVID vaccineafter more than 120 teens were hospitalized after being vaccinated.

According to the province’s Center for Disease Control (CDC), the teens were hospitalized for symptoms ranging from nausea and high fevers to breathing difficulties — with 17 children exhibiting severe reactions.

Thanh Hoa authorities have yet to confirm Pfizer’s COVID vaccine caused the teens’ symptoms, VN Express International reported.

Vu Van Chinh, director of the Ha Trung District General Hospital, said side-effects following vaccination are normal but are more likely to happen in children than adults.

Luong Ngoc Truong, director of the CDC, said although the province stopped using the current vaccine batch, “We still have other batches, also Pfizer vaccines, so we will continue vaccinating the children.”

The suspended batch was put into storage and could be used later for other groups like adults, Truong added.

Last week, four workers in Thanh Hoa’s Kim Viet Shoe factory died — also due to “overreaction” — after receiving the Vero Cell COVID vaccine, authorized in May by the World Health Organization for emergency use.

Three Vietnamese children die after Pfizer vaccine

Vietnam on Nov. 30 rolled out its COVID vaccination program for children 15 to 17 years old with Pfizer’s vaccine. Since then, three children have died after receiving their first dose. The cause of death was “overreaction to the vaccine.”

One of the three deaths reported in Vietnam includes a 12-year-old boy in the southern province of Binh Phuoc who died one day after his first Pfizer shot.

The boy received his vaccine Monday afternoon and was sent home to rest. After dinner, he experienced dizziness, abdominal pain and diarrhea. He was taken to a local hospital and then transferred to two others, but died Tuesday morning.

The Binh Phuoc Department of Health set up an expert panel to determine the cause of the 12-year-old’s death.

A 16-year-old boy in the northern Bac Giang Province, and a ninth-grade girl in Hanoi, both died Sunday after receiving Pfizer’s COVID vaccine.

The Health Ministry said both deaths were caused by “overreaction to the vaccine,” not by a problem with the quality of the vaccine or the vaccination process.

Drugmakers Pfizer and Merck on Nov. 24 agreed to give licenses to firms in Vietnam to produce COVID treatment pills — paxlovid (Pfizer) and molnupiravir (Merck).

Vietnam is one of 95 low- and middle-income countries allowed to produce the pills through a voluntary licensing agreement with Medicines Patent Pool, an international public health group backed by the United Nations.

According to the latest data from the U.S. Vaccine Adverse Event Reporting System, there have been 18,558 reported adverse events following Pfizer’s COVID vaccine among 12 to 17-year-olds.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Megan Redshaw is a freelance reporter for The Defender. She has a background in political science, a law degree and extensive training in natural health.

Featured image is from CHD


Articles by: Megan Redshaw

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]